Disparities in the global cancer burden attributable to modifiable risk factors: a systematic analysis for the Global Burden of Disease Study 2021.

Comprehensive analysis of colorectal cancer burden in G20 countries from 1990 to 2023 and projections to 2030: findings from the Global Burden of Disease Study 2023.

Despite substantial declines in age-standardized mortality and DALY rates, absolute CRC burden in G20 countries has increased dramatically over three decades, driven by population growth and aging.

Stroke Burden Attributable to Risk Factors in the Americas, 1990 to 2021: A Temporal Trends Analysis From the GBD Study 2021.

Stroke burden attributable to modifiable risk factors declined overall, but marked disparities persisted; high systolic blood pressure remained dominant, whereas stalled or increasing burden from obesity, metabolic, and dietary risks highlights the need for equity-focused prevention across the Americas.

Age-specific burden of cervical cancer and attributable risk factors in Asia, 1990-2023: A global burden of disease study 2023.

Cervical cancer burden attributable to unsafe sex showed the highest DALY rate among females aged 50-69 years and the highest mortality rate among those aged 70 years or older, and overall, cervical cancer burden exhibited an inverse association with SDI.

Analysis of the global, regional, and national burden of kidney cancer and projections until 2036

A notable 16% increase in the age-standardized incidence rate for kidney cancer is indicated, while the age-standardized death rate decreased, and promising indications suggest a future decrease in the burden associated with kidney cancer.

Global inequalities in cancer burden attributable to low fruit and vegetable intake: an analysis of GBD 2021 data

Burden of chronic kidney disease and its attributable risk factors in 204 countries and territories, 1990–2021: Results from the Global Burden of Disease study 2021

The global burden of CKD continues to rise, with mortality and DALYs increasing particularly in low- and middle-income countries, and high blood glucose, hypertension, and obesity were identified as the leading contributors to CKD-related DALYs globally.